Juvenile idiopathic arthritis

Summary Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptom...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2007-03, Vol.369 (9563), p.767-778
Main Authors: Ravelli, Angelo, Dr, Martini, Alberto, Prof
Format: Article
Language:English
Subjects:
Adolescent
Adults
Age
Anemia
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Antirheumatic agents
Arthritis
Arthritis, Juvenile - classification
Arthritis, Juvenile - diagnosis
Arthritis, Juvenile - genetics
Arthritis, Juvenile - immunology
Arthritis, Juvenile - therapy
Biological and medical sciences
Bone density
Child
Child development
Child, Preschool
Children & youth
Chronic Disease
Chronic illnesses
Classification
Diagnosis, Differential
Disease control
Disease Progression
Diseases of the osteoarticular system
Drug development
Drugs
Environmental factors
Female
Fever
General aspects
Heterogeneity
HLA Antigens - genetics
Humans
Immune response
Immune system
Immunosuppressive agents
Infant
Inflammation
Inflammation - immunology
Inflammatory joint diseases
Injections, Intra-Articular
Internal Medicine
Joint surgery
Laboratories
Male
Medical sciences
Molecular chains
Pathogenesis
Patients
Physical Therapy Modalities
Prognosis
Psoriasis
Rheumatic diseases
Rheumatoid arthritis
Rheumatology
Risk factors
Steroids - administration & dosage
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c581t-4a9de8a9f314171db5deba07e568877baeded8c6c723a2c1607fe4781621daa73
cites cdi_FETCH-LOGICAL-c581t-4a9de8a9f314171db5deba07e568877baeded8c6c723a2c1607fe4781621daa73
container_end_page 778
container_issue 9563
container_start_page 767
container_title The Lancet (British edition)
container_volume 369
creator Ravelli, Angelo, Dr
Martini, Alberto, Prof
description Summary Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background. The cause of disease is still poorly understood but seems to be related to both genetic and environmental factors, which result in the heterogeneity of the illness. Although none of the available drugs has a curative potential, prognosis has greatly improved as a result of substantial progresses in disease management. The most important new development has been the introduction of drugs such as anticytokine agents, which constitute a valuable treatment option for patients who are resistant to conventional antirheumatic agents. Further insights into the disease pathogenesis and treatment will be provided by the continuous advances in understanding of the mechanisms connected to the immune response and inflammatory process, and by the development of new drugs that are able to inhibit selectively single molecules or pathways.
doi_str_mv 10.1016/S0140-6736(07)60363-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70228198</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673607603638</els_id><sourcerecordid>2067750298</sourcerecordid><originalsourceid>FETCH-LOGICAL-c581t-4a9de8a9f314171db5deba07e568877baeded8c6c723a2c1607fe4781621daa73</originalsourceid><addsrcrecordid>eNqFkE1rFEEQQBtRzCb6EyJBicTDaPVn9VwSJBg_CHhQwVvT211DOs7OrN0zgfx7Z3YXFwLiqS-vX1U9xo45vOXAzbtvwBVUBqU5A3xjQBpZ2UdswRWqSiv8-Zgt_iIH7LCUWwBQBvRTdsBRSmO0WrDjL-MddamlkxRTv_bDTQonPg83OQ2pPGNPGt8Wer57j9iPqw_fLz9V118_fr58f10FbflQKV9Hsr5uJFcceVzqSEsPSNpYi7j0FCnaYAIK6UXgBrAhhZYbwaP3KI_Y6613nfvfI5XBrVIJ1La-o34sDkEIy2s7ga8egLf9mLtpNyfAIGoQG-rlvyhe11xIKeoJ0lso5L6UTI1b57Ty-d5xcHNit0ns5n4O0G0Su1n-YicflyuK-1-7phNwugN8Cb5tsu9CKnvOammtmI--2HI0lb1LlF0JibpAMWUKg4t9-u8q5w8MoU1dmob-onsq-6NdEQ62ktkBuDFY-Qf7cqoR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199123329</pqid></control><display><type>article</type><title>Juvenile idiopathic arthritis</title><source>ScienceDirect Journals</source><creator>Ravelli, Angelo, Dr ; Martini, Alberto, Prof</creator><creatorcontrib>Ravelli, Angelo, Dr ; Martini, Alberto, Prof</creatorcontrib><description>Summary Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background. The cause of disease is still poorly understood but seems to be related to both genetic and environmental factors, which result in the heterogeneity of the illness. Although none of the available drugs has a curative potential, prognosis has greatly improved as a result of substantial progresses in disease management. The most important new development has been the introduction of drugs such as anticytokine agents, which constitute a valuable treatment option for patients who are resistant to conventional antirheumatic agents. Further insights into the disease pathogenesis and treatment will be provided by the continuous advances in understanding of the mechanisms connected to the immune response and inflammatory process, and by the development of new drugs that are able to inhibit selectively single molecules or pathways.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(07)60363-8</identifier><identifier>PMID: 17336654</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Adolescent ; Adults ; Age ; Anemia ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Antirheumatic agents ; Arthritis ; Arthritis, Juvenile - classification ; Arthritis, Juvenile - diagnosis ; Arthritis, Juvenile - genetics ; Arthritis, Juvenile - immunology ; Arthritis, Juvenile - therapy ; Biological and medical sciences ; Bone density ; Child ; Child development ; Child, Preschool ; Children &amp; youth ; Chronic Disease ; Chronic illnesses ; Classification ; Diagnosis, Differential ; Disease control ; Disease Progression ; Diseases of the osteoarticular system ; Drug development ; Drugs ; Environmental factors ; Female ; Fever ; General aspects ; Heterogeneity ; HLA Antigens - genetics ; Humans ; Immune response ; Immune system ; Immunosuppressive agents ; Infant ; Inflammation ; Inflammation - immunology ; Inflammatory joint diseases ; Injections, Intra-Articular ; Internal Medicine ; Joint surgery ; Laboratories ; Male ; Medical sciences ; Molecular chains ; Pathogenesis ; Patients ; Physical Therapy Modalities ; Prognosis ; Psoriasis ; Rheumatic diseases ; Rheumatoid arthritis ; Rheumatology ; Risk factors ; Steroids - administration &amp; dosage ; Treatment Outcome</subject><ispartof>The Lancet (British edition), 2007-03, Vol.369 (9563), p.767-778</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Limited Mar 3-Mar 9, 2007</rights><rights>Copyright Elsevier Limited Mar 3, 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c581t-4a9de8a9f314171db5deba07e568877baeded8c6c723a2c1607fe4781621daa73</citedby><cites>FETCH-LOGICAL-c581t-4a9de8a9f314171db5deba07e568877baeded8c6c723a2c1607fe4781621daa73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18538827$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17336654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ravelli, Angelo, Dr</creatorcontrib><creatorcontrib>Martini, Alberto, Prof</creatorcontrib><title>Juvenile idiopathic arthritis</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Summary Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background. The cause of disease is still poorly understood but seems to be related to both genetic and environmental factors, which result in the heterogeneity of the illness. Although none of the available drugs has a curative potential, prognosis has greatly improved as a result of substantial progresses in disease management. The most important new development has been the introduction of drugs such as anticytokine agents, which constitute a valuable treatment option for patients who are resistant to conventional antirheumatic agents. Further insights into the disease pathogenesis and treatment will be provided by the continuous advances in understanding of the mechanisms connected to the immune response and inflammatory process, and by the development of new drugs that are able to inhibit selectively single molecules or pathways.</description><subject>Adolescent</subject><subject>Adults</subject><subject>Age</subject><subject>Anemia</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Antirheumatic agents</subject><subject>Arthritis</subject><subject>Arthritis, Juvenile - classification</subject><subject>Arthritis, Juvenile - diagnosis</subject><subject>Arthritis, Juvenile - genetics</subject><subject>Arthritis, Juvenile - immunology</subject><subject>Arthritis, Juvenile - therapy</subject><subject>Biological and medical sciences</subject><subject>Bone density</subject><subject>Child</subject><subject>Child development</subject><subject>Child, Preschool</subject><subject>Children &amp; youth</subject><subject>Chronic Disease</subject><subject>Chronic illnesses</subject><subject>Classification</subject><subject>Diagnosis, Differential</subject><subject>Disease control</subject><subject>Disease Progression</subject><subject>Diseases of the osteoarticular system</subject><subject>Drug development</subject><subject>Drugs</subject><subject>Environmental factors</subject><subject>Female</subject><subject>Fever</subject><subject>General aspects</subject><subject>Heterogeneity</subject><subject>HLA Antigens - genetics</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunosuppressive agents</subject><subject>Infant</subject><subject>Inflammation</subject><subject>Inflammation - immunology</subject><subject>Inflammatory joint diseases</subject><subject>Injections, Intra-Articular</subject><subject>Internal Medicine</subject><subject>Joint surgery</subject><subject>Laboratories</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Molecular chains</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Physical Therapy Modalities</subject><subject>Prognosis</subject><subject>Psoriasis</subject><subject>Rheumatic diseases</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatology</subject><subject>Risk factors</subject><subject>Steroids - administration &amp; dosage</subject><subject>Treatment Outcome</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkE1rFEEQQBtRzCb6EyJBicTDaPVn9VwSJBg_CHhQwVvT211DOs7OrN0zgfx7Z3YXFwLiqS-vX1U9xo45vOXAzbtvwBVUBqU5A3xjQBpZ2UdswRWqSiv8-Zgt_iIH7LCUWwBQBvRTdsBRSmO0WrDjL-MddamlkxRTv_bDTQonPg83OQ2pPGNPGt8Wer57j9iPqw_fLz9V118_fr58f10FbflQKV9Hsr5uJFcceVzqSEsPSNpYi7j0FCnaYAIK6UXgBrAhhZYbwaP3KI_Y6613nfvfI5XBrVIJ1La-o34sDkEIy2s7ga8egLf9mLtpNyfAIGoQG-rlvyhe11xIKeoJ0lso5L6UTI1b57Ty-d5xcHNit0ns5n4O0G0Su1n-YicflyuK-1-7phNwugN8Cb5tsu9CKnvOammtmI--2HI0lb1LlF0JibpAMWUKg4t9-u8q5w8MoU1dmob-onsq-6NdEQ62ktkBuDFY-Qf7cqoR</recordid><startdate>20070303</startdate><enddate>20070303</enddate><creator>Ravelli, Angelo, Dr</creator><creator>Martini, Alberto, Prof</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20070303</creationdate><title>Juvenile idiopathic arthritis</title><author>Ravelli, Angelo, Dr ; Martini, Alberto, Prof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c581t-4a9de8a9f314171db5deba07e568877baeded8c6c723a2c1607fe4781621daa73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adults</topic><topic>Age</topic><topic>Anemia</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Antirheumatic agents</topic><topic>Arthritis</topic><topic>Arthritis, Juvenile - classification</topic><topic>Arthritis, Juvenile - diagnosis</topic><topic>Arthritis, Juvenile - genetics</topic><topic>Arthritis, Juvenile - immunology</topic><topic>Arthritis, Juvenile - therapy</topic><topic>Biological and medical sciences</topic><topic>Bone density</topic><topic>Child</topic><topic>Child development</topic><topic>Child, Preschool</topic><topic>Children &amp; youth</topic><topic>Chronic Disease</topic><topic>Chronic illnesses</topic><topic>Classification</topic><topic>Diagnosis, Differential</topic><topic>Disease control</topic><topic>Disease Progression</topic><topic>Diseases of the osteoarticular system</topic><topic>Drug development</topic><topic>Drugs</topic><topic>Environmental factors</topic><topic>Female</topic><topic>Fever</topic><topic>General aspects</topic><topic>Heterogeneity</topic><topic>HLA Antigens - genetics</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunosuppressive agents</topic><topic>Infant</topic><topic>Inflammation</topic><topic>Inflammation - immunology</topic><topic>Inflammatory joint diseases</topic><topic>Injections, Intra-Articular</topic><topic>Internal Medicine</topic><topic>Joint surgery</topic><topic>Laboratories</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Molecular chains</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Physical Therapy Modalities</topic><topic>Prognosis</topic><topic>Psoriasis</topic><topic>Rheumatic diseases</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatology</topic><topic>Risk factors</topic><topic>Steroids - administration &amp; dosage</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ravelli, Angelo, Dr</creatorcontrib><creatorcontrib>Martini, Alberto, Prof</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>Biological Sciences</collection><collection>ProQuest Family Health</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Health Management</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest research library</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ravelli, Angelo, Dr</au><au>Martini, Alberto, Prof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Juvenile idiopathic arthritis</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2007-03-03</date><risdate>2007</risdate><volume>369</volume><issue>9563</issue><spage>767</spage><epage>778</epage><pages>767-778</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Summary Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background. The cause of disease is still poorly understood but seems to be related to both genetic and environmental factors, which result in the heterogeneity of the illness. Although none of the available drugs has a curative potential, prognosis has greatly improved as a result of substantial progresses in disease management. The most important new development has been the introduction of drugs such as anticytokine agents, which constitute a valuable treatment option for patients who are resistant to conventional antirheumatic agents. Further insights into the disease pathogenesis and treatment will be provided by the continuous advances in understanding of the mechanisms connected to the immune response and inflammatory process, and by the development of new drugs that are able to inhibit selectively single molecules or pathways.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>17336654</pmid><doi>10.1016/S0140-6736(07)60363-8</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2007-03, Vol.369 (9563), p.767-778
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_70228198
source ScienceDirect Journals
subjects Adolescent
Adults
Age
Anemia
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Antirheumatic agents
Arthritis
Arthritis, Juvenile - classification
Arthritis, Juvenile - diagnosis
Arthritis, Juvenile - genetics
Arthritis, Juvenile - immunology
Arthritis, Juvenile - therapy
Biological and medical sciences
Bone density
Child
Child development
Child, Preschool
Children & youth
Chronic Disease
Chronic illnesses
Classification
Diagnosis, Differential
Disease control
Disease Progression
Diseases of the osteoarticular system
Drug development
Drugs
Environmental factors
Female
Fever
General aspects
Heterogeneity
HLA Antigens - genetics
Humans
Immune response
Immune system
Immunosuppressive agents
Infant
Inflammation
Inflammation - immunology
Inflammatory joint diseases
Injections, Intra-Articular
Internal Medicine
Joint surgery
Laboratories
Male
Medical sciences
Molecular chains
Pathogenesis
Patients
Physical Therapy Modalities
Prognosis
Psoriasis
Rheumatic diseases
Rheumatoid arthritis
Rheumatology
Risk factors
Steroids - administration & dosage
Treatment Outcome
title Juvenile idiopathic arthritis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T09%3A11%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Juvenile%20idiopathic%20arthritis&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Ravelli,%20Angelo,%20Dr&rft.date=2007-03-03&rft.volume=369&rft.issue=9563&rft.spage=767&rft.epage=778&rft.pages=767-778&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(07)60363-8&rft_dat=%3Cproquest_cross%3E2067750298%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c581t-4a9de8a9f314171db5deba07e568877baeded8c6c723a2c1607fe4781621daa73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199123329&rft_id=info:pmid/17336654&rfr_iscdi=true